T1	Non-query-able 0 36	Previous randomization in this study
T2	Drug 53 67	IV antibiotics
T3	Temporal 68 99	in the 6 weeks prior to Visit 1
T4	Reference_point 92 99	Visit 1
R1	Has_index Arg1:T3 Arg2:T4	
R2	Has_temporal Arg1:T2 Arg2:T3	
T5	Observation 101 137	Admission to the intensive care unit
T6	Visit 118 137	intensive care unit
R3	multi Arg1:T5 Arg2:T6	
T7	Condition 150 172	pulmonary exacerbation
R4	AND Arg1:T5 Arg2:T7	
T8	Temporal 173 206	in the two weeks prior to Visit 2
T9	Reference_point 199 206	Visit 2
R5	Has_index Arg1:T8 Arg2:T9	
R6	Subsumes Arg1:T7 Arg2:T8	
T11	Procedure 238 262	desensitization protocol
T10	Negation 208 214	unless
R7	Has_negation Arg1:T11 Arg2:T10	
T12	Condition 264 276	Pneumothorax
T13	Temporal 277 310	in the two weeks prior to Visit 2
T14	Reference_point 303 310	Visit 2
R8	Has_index Arg1:T13 Arg2:T14	
T15	Condition 312 329	Primary diagnosis
T16	Observation 334 357	current hospitalization
R9	Has_context Arg1:T15 Arg2:T16	
T17	Negation 361 370	unrelated
T18	Condition 384 410	lower respiratory symptoms
T19	Qualifier 374 383	worsening
R10	Has_qualifier Arg1:T18 Arg2:T19	
*	NOT T18 T17
T20	Condition 418 437	pulmonary clean out
T21	Condition 439 477	distal intestinal obstruction syndrome
T22	Condition 479 483	DIOS
T23	Condition 486 495	sinusitis
*	OR T20 T21 T23
R11	Subsumes Arg1:T21 Arg2:T22	
T24	Scope 411 496	(e.g., pulmonary clean out, distal intestinal obstruction syndrome (DIOS), sinusitis)
R12	Subsumes Arg1:T18 Arg2:T24	
T25	Condition 506 516	hemoptysis
T26	Qualifier 498 505	Massive
T27	Multiplier 528 536	> 250 cc
T28	Temporal 537 556	in a 24 hour period
T29	Multiplier 560 570	100 cc/day
T30	Temporal 571 594	over 4 consecutive days
T31	Temporal 605 638	in the two weeks prior to Visit 2
T32	Reference_point 631 638	Visit 2
R13	Has_index Arg1:T31 Arg2:T32	
R14	Has_qualifier Arg1:T25 Arg2:T26	
T33	Scope 528 594	> 250 cc in a 24 hour period or 100 cc/day over 4 consecutive days
*	OR T27 T29
R15	Has_scope Arg1:T25 Arg2:T33	
R16	Has_temporal Arg1:T25 Arg2:T31	
T34	Condition 648 670	pulmonary exacerbation
T35	Condition 692 731	allergic bronchopulmonary aspergillosis
T36	Condition 733 737	ABPA
R17	Subsumes Arg1:T35 Arg2:T36	
R18	AND Arg1:T34 Arg2:T35	
T38	Temporal 740 750;799 816	At Visit 1 more than 2 weeks
T37	Drug 822 832	prednisone
T39	Multiplier 847 856	>10mg/day
R19	Has_multiplier Arg1:T37 Arg2:T39	
R20	Has_temporal Arg1:T37 Arg2:T38	
T40	Reference_point 743 750	Visit 1
R21	Has_index Arg1:T38 Arg2:T40	
T41	Condition 869 896	solid organ transplantation
T42	Drug 908 929	antimicrobial therapy
T43	Qualifier 939 968	non-tuberculous mycobacterium
R22	Has_qualifier Arg1:T42 Arg2:T43	
T44	Qualifier 976 988	M. abscessus
T45	Qualifier 990 1006	M. avium complex
R23	Subsumes Arg1:T43 Arg2:T44	
R24	Subsumes Arg1:T43 Arg2:T45	
T46	Temporal 1008 1041	in the two weeks prior to Visit 2
T47	Reference_point 1034 1041	Visit 2
R25	Has_index Arg1:T46 Arg2:T47	
R26	Has_temporal Arg1:T42 Arg2:T46	
